Evaluation of the efficacy and safety of local steroid application for prevention of chest pain after esophageal ESD.

Evaluation of the efficacy and safety of local steroid application for prevention of chest pain after esophageal ESD. - Evaluation of steroid application for prevention of chest pain after esophageal ESD.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013737

Enrollment

Registered

2014-05-09

Start date

2014-05-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Superficial esophageal cancer

Interventions

Local steroid application after ESD No treatment after ESD

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with superficial esophageal cancer who plan to undergo ESD

Exclusion criteria

Exclusion criteria: Patients who regularly take analgesic agent or steroid. Patients with serious cardiovascular or pulmonary disease, renal dysfunction, liver dysfunction and endocrine metabolic disorder. Patient who have been judged as inappropriate for this study.

Design outcomes

Primary

Measure	Time frame
To assess the frequency and severity of pain using a questionnaire	—

Secondary

Measure	Time frame
The frequency of the complication related to steroid administration	—

Countries

Japan

Contacts

Public ContactNonaka Takashi

Yokohama City University Hospital Department of Gastroenterology and Hepatology

nonaka@yokohama-cu.ac.jp045-787-2640

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026